Sarcoidosis on PET-CT: — The Great Mimic

Not with certainty. Both conditions cause lymph nodes to absorb large amounts of FDG glucose, and the pattern of uptake can be nearly identical — particularly the bilateral hilar distribution that is classic for sarcoidosis and also seen in Hodgkin lymphoma. An experienced radiologist may note which diagnosis seems more likely, but that is not the same as a confirmed answer. Tissue examination is the only reliable way to distinguish the two.

Your oncologist will make that decision based on your full clinical picture, not the scan alone. In many cases, yes — particularly when lymphoma is a serious possibility and treatment would differ — because the consequences of treating one condition as the other are significant. There are situations where the clinical picture is strongly consistent with sarcoidosis, but that judgement belongs to your treating team, not to the scan report.

Sarcoidosis is managed very differently from lymphoma. In a proportion of patients it resolves on its own over time without any treatment. Others need monitoring or medication to manage symptoms and protect affected organs such as the lungs or eyes. Your team will explain what the biopsy result means for your situation specifically, including whether treatment is needed or whether watchful waiting is the right approach.

Granulomas — the clusters of immune cells that form in sarcoidosis — are metabolically active. They consume glucose at a higher rate than normal tissue, in the same way cancer cells do. This is why the PET scan cannot distinguish between the two by tracer uptake alone: the biochemical mechanism that makes cancer visible on PET also makes active inflammation visible. The scan shows metabolic activity, not the reason for it.

Yes, and in India this is a genuinely important possibility. TB can involve the hilar and mediastinal nodes and light up on PET-CT in a way that overlaps with both sarcoidosis and lymphoma. This is why your report may list all three, and why tissue confirmation matters. The biopsy sample can be sent for TB culture and molecular testing at the same time as it is examined for granulomas and cancer cells, so the single procedure addresses all three possibilities at once.

Most histopathology results — the microscope examination for granulomas or cancer cells — come back within several days to a week. If TB testing is added, culture results can take longer, though rapid molecular tests can give a TB answer more quickly. Your team will tell you which tests are being sent and when to expect the result, so you are not waiting without a timeline.